Metal binding important for metformin action

Metal binding important for metformin action
The ability of metformin to bind mitochondrial copper may be essential to its mechanism of action, according to a study published online April 9 in Diabetes.

(HealthDay) -- The ability of metformin to bind mitochondrial copper may be essential to its mechanism of action, according to a study published online April 9 in Diabetes.

Noting that the of metformin is unclear but most evidence has shown that the drug binds to , most stably to copper, rather than protein targets, Lisa Logie, Ph.D., from the University of Dundee in the United Kingdom, and colleagues interfered with the ability of metformin to bind copper and examined the impact on cellular responses.

The researchers found that copper sequestration interfered with the known effects of metformin on AMP-activated (AMPK)-dependent signaling and S6 , which were regulated independently. The metformin-copper interaction was stabilized by extensive pi-electron delocalization, which allowed regulation of AMPK, production of glucose, gluconeogenic gene expression, mitochondrial respiration, and mitochondrial copper binding. In contrast, direct modification of the metal-liganding groups of the biguanide structure prevented regulation of S6 phosphorylation. Further studies showed that pioglitazone also targeted mitochondrial copper.

"In summary, this study indicates that effects of metformin and related compounds on cell responses depend on their ability to interact with copper," Logie and colleagues conclude. "More broadly, our results suggest that the number of targets for drug discovery could be widened not only by investigating nonprotein targets such as copper, but also by considering the role of metal-induced effects on chemical bonding and conformational geometries of drug structures."

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Diabetes drug could work against Alzheimer's

Nov 24, 2010

Scientists from Berlin, Bonn and Dundee show in animal models that the diabetes drug metformin has an effect against one of the main causes of the Alzheimer's disease.

Copper + love chemical = big sulfur stink

Feb 06, 2012

When Hiroaki Matsunami, Ph.D., at Duke set out to study a chemical in male mouse urine called MTMT that attracts female mice, he didn't think he would stumble into a new field of study.

Diabetes drug can prevent heart disease

Mar 26, 2012

The widely used diabetes medicine metformin can have protective effects on the heart, reveals a new study conducted at the Sahlgrenska Academy, at the University of Gothenburg, Sweden.

Recommended for you

Low-carb diet recommended for diabetics

5 hours ago

A new study involving researchers from the University of Alabama at Birmingham and other institutions says patients with Type 1 and Type 2 diabetes should eat a diet low in carbohydrates.

Shift work linked to heightened risk of type 2 diabetes

Jul 24, 2014

Shift work is linked to a heightened risk of developing type 2 diabetes, with the risk seemingly greatest among men and those working rotating shift patterns, indicates an analysis of the available evidence published online ...

Rosemary and oregano contain diabetes-fighting compounds

Jul 23, 2014

The popular culinary herbs oregano and rosemary are packed with healthful compounds, and now lab tests show they could work in much the same way as prescription anti-diabetic medication, scientists report. In their new study ...

User comments